XPH vs. XLVI

Last updated Jun 24, 2026

XPH (SPDR S&P Pharmaceuticals ETF) and XLVI (State Street Health Care Select Sector SPDR Premium Income ETF) are both exchange-traded funds - XPH is a Health & Biotech Equities fund tracking the S&P Pharmaceuticals Select Industry Index, while XLVI is a Derivative Income fund actively managed by State Street. XPH is passively managed, while XLVI is actively managed. A 0.54 correlation means they provide meaningful diversification when combined. Both charge a 0.35% expense ratio.

Performance

XPH vs. XLVI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SPDR S&P Pharmaceuticals ETF (XPH) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, XPH achieves a 13.09% return, which is significantly higher than XLVI's 2.50% return.

XPH

• 1D: 1.77%
• 1M: 9.48%
• YTD: 13.09%
• 6M: 12.03%
• 1Y: 55.30%
• 3Y*: 16.62%
• 5Y*: 5.15%
• 10Y*: 5.45%

XLVI

• 1D: 1.53%
• 1M: 2.15%
• YTD: 2.50%
• 6M: 2.57%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

XPH vs. XLVI - Yearly Performance Comparison

	2026 (YTD)	2025
XPH SPDR S&P Pharmaceuticals ETF	13.09%	32.91%
XLVI State Street Health Care Select Sector SPDR Premium Income ETF	2.50%	12.41%

Correlation

The correlation between XPH and XLVI is 0.54, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (All Time) Calculated using the full available price history since Jul 30, 2025	0.54

XPH vs. XLVI - Sectors Allocation Comparison

Sectors	XPH	XLVI
Healthcare	100.0%	100.0%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	100.2%
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

XPH vs. XLVI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XPH

XPH Risk / Return Rank: 82
XPH Sharpe Ratio Rank: 84
XPH Sortino Ratio Rank: 82
XPH Omega Ratio Rank: 75
XPH Calmar Ratio Rank: 87
XPH Martin Ratio Rank: 84

XLVI

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XPH vs. XLVI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Pharmaceuticals ETF (XPH) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	XPH	XLVI	Difference
Sharpe ratio: Return per unit of total volatility	2.55	—	—
Sortino ratio: Return per unit of downside risk	3.43	—	—
Omega ratio: Gain probability vs. loss probability	1.41	—	—
Calmar ratio: Return relative to maximum drawdown	4.64	—	—
Martin ratio: Return relative to average drawdown	16.63	—	—

Drawdowns

XPH vs. XLVI - Drawdown Comparison

The maximum XPH drawdown since its inception was -48.03%, which is greater than XLVI's maximum drawdown of -8.14%. Use the drawdown chart below to compare losses from any high point for XPH and XLVI.

Drawdown Indicators

	XPH	XLVI	Difference
Max Drawdown Largest peak-to-trough decline	-48.03%	-8.14%	-39.89%
Max Drawdown (1Y) Largest decline over 1 year	-11.97%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-23.57%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-31.63%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-35.97%	—	—
Current Drawdown Current decline from peak	0.00%	-0.97%	+0.97%
Average Drawdown Average peak-to-trough decline	-17.21%	-1.94%	-15.27%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.33%	—	—

Volatility

Volatility by Period

	XPH	XLVI	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.27%	—	—
Volatility (6M) Calculated over the trailing 6-month period	16.67%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	21.77%	11.06%	+10.71%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	20.92%	11.06%	+9.86%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	22.09%	11.06%	+11.03%

XPH vs. XLVI - Expense Ratio Comparison

Both XPH and XLVI have an expense ratio of 0.35%.

Dividends

XPH vs. XLVI - Dividend Comparison

XPH's dividend yield for the trailing twelve months is around 0.53%, less than XLVI's 11.17% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
XLVI State Street Health Care Select Sector SPDR Premium Income ETF	11.17%	5.73%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
XPH SPDR S&P Pharmaceuticals ETF	0.53%	0.83%	1.58%	1.28%	1.64%	0.95%	0.47%	0.64%	0.65%	0.67%	0.63%	7.15%

Frequently Asked Questions

Can I hold both XPH and XLVI in my portfolio?

XPH and XLVI have a correlation of 0.54, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, XPH or XLVI?

Both ETFs have the same 0.35% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, XPH or XLVI?

XPH and XLVI have the same expense ratio: 0.35% per year.

Which ETF pays a higher dividend yield, XPH or XLVI?

XLVI has the higher dividend yield at 11.17%, compared with 0.53% for XPH.

What is the main difference between XPH and XLVI?

XPH is categorized as Health & Biotech Equities, while XLVI is Derivative Income.